Biomnis, European leader in specialised medical pathology, emanates from a laboratory founded by Marcel Mérieux in 1897. Biomnis is based on a concept of specialised biology that is entirely dedicated to excellence, innovation and technological investment.
With a menu of over 2,500 assays, Biomnis laboratories has established its reputation for the development of new novel tests and the availability of routine and esoteric tests. As a partner of first-line medical laboratories, Biomnis provides its highly skilled expertise to all its stakeholders (both private and hospital-based laboratories) on a daily basis.
Day after day, the pathologists at Biomnis can help both their fellow pathologists and prescribing physicians with the interpretation of results and contribute to improve prevention, earlier screening tests, more precise and rapid diagnoses, as well as a greater efficacy of therapeutic treatments.
Striving for excellence in public health
With close to 30,000 diagnostic tests performed per day, Biomnis is committed to providing all patients from across the globe, with access to the most specialised and innovative screening, diagnosis, and monitoring or therapeutic adjustment techniques available.
Through its long-term partnerships with International logistical courriers, Biomnis possesses the tools and know-how to ensure sample integrity on a global scale, from collection to its arrival in Biomnis laboratories. Biomnis is committed to guaranteeing the same high quality of care and access to innovation to patients all over the world.
Three areas of expertise
Specialised medical pathology
Biomnis focuses mainly on specialised pathology testing, which requires highly skilled expertise, and which cannot be performed in routine private or hospital-based laboratories. Biomnis specialises in all areas of pathology and testing is performed using the most recent and cutting-edge techniques, which necessitate complex calibrations and validations, highly qualified experts and sophisticated equipment.
The Clinical Trials Department at Biomnis was created in 1998, and runs clinical studies and develops assay methods for the pharmaceutical industry.
Biomnis also has a forensic medicine laboratory which is accredited to perform genetic fingerprinting used to identify or exculpate suspects and also in paternity cases. Our legal experts from the fingerprinting laboratory are consulted in various fields : evidence sample analyses, profiles for the Criminal Registry, mitochondrial DNA sequencing and paternity tests.